<?xml version="1.0" encoding="UTF-8"?>
<p>The current situation of COVID-19 pandemic has accentuated the urgency of the demand for effective treatments. Based on previous data concerning activities against other viruses and empirical knowledge from treatments used in case reports, several drugs have entered clinical trial phases to access their therapeutic potential against SARS-CoV-2. In this section, we discuss the current knowledge on the most promising candidates for the treatment of COVID-19. Data for these drugs are summarized in 
 <xref rid="T2" ref-type="table">Table 2</xref>.
</p>
